Daniel Scavilla compensation by year
GLOBUS MEDICAL Summary Compensation Table · all 7 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Salary | $334,750 | $344,793 | $355,136 | $437,064 | $463,500 | $481,077 | $284,616 |
| Bonus | $0 | $0 | $0 | $194,117 | $150,000 | $0 | $0 |
| Stock awards | $0 | $0 | $0 | $0 | — | $0 | $0 |
| Option awards | $1,205,006 | $666,149 | $1,087,147 | $2,447,972 | $2,896,394 | $2,936,886 | $5,006,645 |
| Non-equity incentive | $207,500 | $263,750 | $400,000 | $705,883 | $1,021,500 | $1,404,150 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | — | $0 | $0 |
| All other | $37,200 | $37,183 | $37,280 | $33,282 | $32,980 | $36,547 | $25,678 |
| Total | $1,784,456 | $1,311,875 | $1,879,563 | $3,818,318 | $4,564,374 | $4,858,660 | $5,316,939 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GLOBUS MEDICAL INC DEF 14A filed April 24, 2026, accession 0001628280-26-027196, and prior-year filings. Open the filing on EDGAR.
How this page was built: the GLOBUS MEDICAL INC filed document, accession 0001628280-26-027196. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 10,833 | — | $63.68 |
| Option | 6,875 | — | $53.02 |
| Option | 1,042 | — | $65.05 |
| Option | 140,000 | — | $53.75 |
| Option | 20,000 | — | $79.00 |
| Option | 52,083 | — | $75.18 |
Per the Outstanding Equity Awards at Fiscal Year-End table in GLOBUS MEDICAL INC's FY2024 proxy; value at the fiscal year-end close, as the company printed it.
GLOBUS MEDICAL’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Daniel Scavilla · this page | Former Chief Executive Officer and President | $5,316,939 |
| Keith Pfeil | Chief Executive Officer and President | $4,400,159 |
| David Paul | Chairman of the Board of Directors and Executive Chairman | $4,305,179 |
| Kelly Huller | Executive Vice President, General Counsel and Corporate Secretary | $2,280,832 |
| Kyle Kline | Senior Vice President and Chief Financial Officer | $1,380,258 |
Daniel Scavilla's compensation dossier, GLOBUS MEDICAL
You have read Daniel Scavilla's totals and holdings. The dossier adds each equity grant GLOBUS MEDICAL disclosed for Daniel Scavilla and GLOBUS MEDICAL's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full GLOBUS MEDICAL compensation record
free company briefThis page is one person within GLOBUS MEDICAL's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the GLOBUS MEDICAL proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order GLOBUS MEDICAL's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GLOBUS MEDICAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order GMED
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.